7 Mistakes Companies Make With Workplace Drug Testing
/Most companies don't set out to mishandle drug testing. Errors creep in through inconsistent policies, outdated procedures, or a simple lack of training. Left unchecked, those mistakes expose businesses to legal risk, employee grievances, and results that won't survive scrutiny in a tribunal.
Here are the seven most common mistakes companies make with workplace drug testing, and what you can do instead.
1. Using Low-Quality or Uncertified Testing Equipment
Your testing equipment's quality determines whether results hold up when challenged. Many companies grab the cheapest kits without checking whether they meet occupational health standards. This is where accurate drug testing kits matter; they're the foundation of a defensible testing programme. A kit that hasn't been independently validated or UKCA certified introduces doubt at every turn. If an employee challenges a positive result, a poorly sourced kit is what a legal representative attacks first.
Beyond disputes, inaccurate results cause two kinds of harm: false positives that unfairly penalize employees, and false negatives that let genuine safety risks slip through. Investing in verified, professionally graded equipment isn't optional in safety-sensitive sectors, construction, transport, logistics. You'll notice the difference when a challenge arises; the catch is, by then it's too late.
2. Testing Without a Written Drug and Alcohol Policy
No written policy means no legal standing. Before any test happens, employees need to know:
That drug and alcohol testing is a condition of employment
Which substances are covered
When and how testing will occur (random, for-cause, post-incident)
What happens after a positive result
What support the company offers
A policy also shields the company if dismissal goes to an employment tribunal. Without documented rules, disciplinary action based on a positive test becomes procedurally weak. Have an employment law professional review it, distribute it during initial orientation, and update it whenever the law changes. Verbal agreements or vague staff handbook clauses won't cut it. Put it on paper, get signatures, keep copies.
3. Failing to Train the Staff Who Administer Tests
Untrained administrators rank among the most overlooked risks in workplace drug testing. The person collecting a sample and reading a result needs to grasp the whole process, not just the critical bits. Sample collection errors, improper chain-of-custody handling, failure to observe the correct time window, poor documentation; each one creates grounds for challenge.
Training should cover:
How to explain the procedure to the person being tested
Correct specimen collection technique
How to record and store results
What to do if a result is contested
Even one procedural gap, reading a test strip at nine minutes instead of ten, can compromise the result. Companies often brief someone once and assume that's sufficient. It's not. Annual refreshers and written SOPs at the point of use are standard in any workplace taking this seriously.
4. Testing Inconsistently Across the Workforce
Selective testing opens the door to discrimination claims. If managers only put forward certain employees for random testing, or one department gets tested constantly while another never does, the programme loses credibility. Employment law doesn't permit uneven rule application. An employee who suspects they were singled out for testing due to age, race, religion, or another protected characteristic has a potential discrimination claim. Random testing must be genuinely random, with a documented selection process that auditors can examine.
Consistency matters at the disciplinary stage too. One employee gets a written warning for a positive test; another in an identical role faces dismissal. That disparity becomes hard to defend. Standardize from beginning to end: who gets tested and what happens when results come back positive.
5. Ignoring Prescription Medications in Your Policy
A positive result doesn't prove misuse. Several legally prescribed medications, opioid-based painkillers, certain antidepressants, benzodiazepines, and ADHD medication trigger positive readings on standard test panels. Companies that treat every positive as a disciplinary matter without asking about prescriptions expose themselves to disability discrimination claims under the Equality Act 2010.
Your policy must include a process. Employees declare relevant medication in confidence before testing, or they submit a doctor's note after a positive result before any disciplinary action starts. Medical Review Officers (MROs) exist for exactly this reason; they evaluate results in light of an employee's full medical picture. Skipping that step is legally risky and ethically wrong. It also damages employee trust in ways that take years to repair.
6. Mishandling the Chain of Custody
Chain of custody is the documented record of every person who handled a sample from collection through laboratory analysis. A broken chain makes a result legally indefensible. Common failures:
Unlabelled or mislabelled sample containers
No witness signature on the collection form
Samples left unsecured before transport
No tamper-evident sealing
Gaps in the transfer log
Skip any of these and a competent legal challenge will expose it. Many companies get the initial collection right but fumble the documentation afterward. Look, the chain of custody paperwork isn't a formality. It's the difference between a result that stands up and one that gets tossed out. Treat each sample like potential legal evidence. Because it is.
7. Neglecting Post-Test Support and Rehabilitation Options
A positive test result is a point in a process, not the end. Companies that move straight to dismissal without exploring support miss both a legal and human obligation. The Advisory, Conciliation and Arbitration Service (ACAS) guidance on substance misuse at work recommends employers consider rehabilitation before reaching for discipline. Offering access to an Employee Assistance Programme (EAP), occupational health referral, or structured return-to-work plan demonstrates procedural fairness.
Dismissal might still be right in certain cases, particularly in safety-sensitive roles after a second offence. But the decision needs to come through a fair process, not as a reflex. Employees who feel the company responded with care are more likely to engage with support, which benefits everyone. Document every step of support you offer; employment tribunals want to see exactly this kind of evidence.
Conclusion
The 7 mistakes companies make with workplace drug testing rarely stem from bad intentions. They're gaps in process, policy, and training that pile up over time. A written policy, consistent application, proper equipment, trained administrators, and fair post-result support work together to build a programme that protects the business and treats employees fairly. Get the basics right and your testing programme becomes an asset, not a liability.
